Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai
Patent
1999-06-21
2000-10-31
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Silicon containing doai
514 78, 514912, A61K 31695, A61K 31685
Patent
active
061403148
ABSTRACT:
Disclosed are methods and materials for visualizing or treating vasculature. The methods and materials in this invention relate to selective and non-invasive visualization, or treatment such as chemical occlusion, of vasculature in the mammalian eye. The methods utilize fluorescent dyes and tissue-reactive substances encapsulated within heat-sensitive liposomes which are subsequently heated to release the contents thereof at a pre-determined anatomical locus. The methods of this invention further utilize tissue-reactive agents which, when activated, are effective to cause localized tissue damage and occlusion of blood vessels and/or blood sinuses. The materials of this invention relate to diagnostic reagents and kits for visualizing or treating a mammalian blood vessel or sinus.
REFERENCES:
patent: 4579430 (1986-04-01), Bille
patent: 4801459 (1989-01-01), Liburdy
patent: 4822335 (1989-04-01), Kawai et al.
patent: 4889129 (1989-12-01), Dougherty
patent: 4891043 (1990-01-01), Zeimer et al.
patent: 4952050 (1990-08-01), Aizu et al.
patent: 5031632 (1991-07-01), Watanabe
patent: 5053006 (1991-10-01), Watson
patent: 5163898 (1992-11-01), Morcos et al.
patent: 5166197 (1992-11-01), Kenney et al.
patent: 5257970 (1993-11-01), Dougherty
patent: 5266302 (1993-11-01), Peyman et al.
patent: 5279298 (1994-01-01), Flower
patent: 5707986 (1998-01-01), Miller et al.
patent: 5798349 (1998-08-01), Guire et al.
Zeimer et al., "Noninvasive Visualization of the Primate Choriocapillary Bed and Study of its Hemodynamics," Abstract 1780; Annual Meeting of Association of Research in Vision and Ophthalmology, Sarasota, FL, May 16, 1992.
Kiryu et al. (1994), "Noninvasive Visualization of the Choriocapillaris and Its Dynamic Filling," Invest. Opthal. & Visual Sci., vol. 25, No. 10, 3724-3731.
Zeimer et al. (1989), "Feasibility of Blood Flow Measurement by Externally Controlled Dye Delivery," 30 Invest. Opthal. & Visual Sci., 4:660-667.
Ogura et al. (1991), "Feasibility of Targeted Drug Delivery to Selective Areas of the Retina," 32 Invest. Opthal. & Visual Sci., 8:2351-2356.
Schmidt-Erfurth et al., (1994), "Selective Occlusion of Subrethinal Neovascularization with Photodynamic Therapy," 91 Opthalmologe 6:789-795.
Asrani et al. (1995), "Systemic Toxicology and Laser Safety of Laser Targeted Angiography with Heat Sensitive Liposomes," 11 J. Ocul. Pharmacol. Ther. 4:575-584.
Asrani et al., (1995), "Feasibility of Laser Targeted Photo-Occlusion of Ocular Vessels," 79 Bri. J. Opthalm. 766-770.
Schmidt-Erfurth et al., (1995), "In Vivo Uptake of Liposomal Benzoporphyrin Derivative and Photothrombosis in Experimental Neovascularization," 17 Lasers in Surg. & Med. 2:178-188.
"Liposomes as Tools in Basic Research and Industry", Phillippot et al. (Ed.) CRS Press 1995.
Liposome Technology, 2nd Ed., vol. I, "Liposome Preparation and Related Techniques," Gregoriadis, (Ed.), CRC Press 1993.
Liposome Technology, 2nd Ed., vol. III, "Interactions of Liposomes with the Biological Milieu," Gregoriadis, (Ed.) CRC Press 1993.
Liposome Technology, 2nd Ed., vol. II, "Entrapment of Drugs and Other Materials," Gregoriadis, (Ed.) CRC Press 1993.
"The Science of Phototherapy," Grossweiner, CRC Press 1994.
"Liposomes," Ostro, (Ed.), Marcel Dekker, Inc. 1987.
"Laser-Targeted dye delivery could revolutionize visualization of choroidal new vessels," in Ocular Surgery News vol. 14, No. 12, p. 39, Jun. 15, 1996.
"Laser-targeted angiography may aid ARMD," in Opthamology Times vol. 22, No. 2, Jan. 15, 1997.
"Laser Targeting of Drugs to Back of the Eye" by Zeimer, 12th Nat'l Eye Research Seminar (1993).
Schmidt-Erfurth et al. (1994), "Vascular Targeting in Photodynamic Occlusion of Subretinal Vessels," Ophthalmology vol. 101, No. 12.
Asrani et al. (1997), "Feasibility of Laser-Targeted Photoocclusion of the Choriocapillary Layer in Rats," Investigative Opthamology & Visual Science, 38: 2702-2710.
Zeimer et al., "Laser Targeted Photo-Occlusion: A Potential Method to Occlude Choroidal Neovascularization," from International Symposium on Experimental and Clinical Ocular Pharmacology and Pharmaceutics, Sep. 28-Oct. 1, 1995.
"Pharmacokinetics of Heat-Sensitive Liposomes for Laser Targeted Drug Delivery" by Grebe et al., from Investigative Opthamology & Visual Science Abstract Book--Part II, May 11-May 16, 1997.
Nishiwaki et al., "Laser Targeted Photodynamic Therapy Occludes Experimental Chordoidal Neovascularization Without Visible Damage to ROE and Choriocappilaris," from Investigative Opthamology & Visual Science, Abstract Book May 10-15, 1998.
Grebe et al., "Effects on the RPE Following Choriocapillaris Occlusion Induced by Laser Targeted Photo-Occlusion and Conventional Photodynamic Therapy," Investigative Opthamology & Visual Science, Annual Meeting Apr. 21-26, 1996.
Asrani et al. (1996), "Selective Visualization of Chorodial Neovascular Membranes," from Investigative Opthamology & Visual Science, 37: 1642-1650.
Yatvin et al. (1978), Science, vol. 202, 1290-1293.
Fay Zohreh
The Johns Hopkins University
LandOfFree
Selective and non-invasive visualization or treatment of vascula does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective and non-invasive visualization or treatment of vascula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective and non-invasive visualization or treatment of vascula will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2051926